Botanical and Plant-Derived Drugs Market to Grow by USD 15.89 bn | Technavio – PRNewswire

Searching for your content…
In-Language News
Contact Us
888-776-0942
from 8 AM – 10 PM ET
News provided by
Feb 28, 2022, 23:00 ET
Share this article
NEW YORK, Feb. 28, 2022 /PRNewswire/ — The botanical and plant-derived drugs market is expected to grow by USD 15.89 bn from 2021 to 2026, progressing at a CAGR of 7.25% during the forecast period, according to Technavio. The report offers an up-to-date analysis as well as exact growth variance and the Y-O-Y growth rate. 
For additional highlights related to the market, Request a Free Sample Report.
Botanical and Plant-Derived Drugs Market 2022-2026: Scope
The botanical and plant-derived drugs market report covers the following areas:
Botanical and Plant-Derived Drugs Market 2022-2026: Drivers and Challenges
The increase in government initiatives is driving the botanical and plant-derived drugs market growth. Herbal medicines are getting significant attention from global healthcare systems. Governments across various countries have made substantial research investments in herbal medicines. Such initiatives will drive market growth during the forecast period.
The low acceptance among physicians is challenging the botanical and plant-derived drugs market growth. For instance, many physicians warn diabetic patients against taking herbal medicines, as there is no proper regulatory mechanism. Such issues may hamper the growth prospects of the market during the forecast period.
Botanical and Plant-Derived Drugs Market 2022-2026: Segmentation
By product, the market has been segmented into plant derived drugs and botanical drugs. The plant-derived drugs segment will have the highest market share growth during the forecast period. The increasing need for effective drugs for the treatment of chronic disorders such as cancer and diabetes has fueled the demand for plant-derived drugs.
By geography, the market has been segmented into Asia, Europe, North America, and Rest Of World (ROW). Asia will have the highest market share growth during the forecast period.
Learn more about the contribution of each segment of the market. Download a Free Sample
Botanical and Plant-Derived Drugs Market 2022-2026: Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the Botanical and Plant-Derived Drugs Market, including Bayer AG, Boehringer Ingelheim International GmbH, Dr. Willmar Schwabe GmbH, and Co. KG, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Jazz Pharmaceuticals Plc, Johnson and Johnson Inc., Merck KGaA, Mitsubishi Chemical Corp., Novartis AG, Pierre Fabre SA, Protalix Biotherapeutics Inc., Quintis (Australia) Pty Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Tilray Inc., and Verdure Sciences Inc. among others.
Subscribe to our "Lite Plan" billed annually at USD 3000 that enables you to download 3 reports/year and view 3 reports/month.
Botanical and Plant-Derived Drugs Market 2022-2026: Key Highlights
Related Reports:
New Drug Delivery Systems Market by Route of Administration and Geography – Forecast and Analysis 2022-2026
Non-small Cell Lung Cancer Drugs Market by Product and Geography – Forecast and Analysis 2022-2026
Botanical And Plant-Derived Drugs Market Scope
Report Coverage
Details
Page number
120
Base year
2021
Forecast period
2022-2026
Growth momentum & CAGR
Accelerate at a CAGR of 7.25%
Market growth 2022-2026
USD 15.89 billion
Market structure
Fragmented
YoY growth (%)
7.02
Regional analysis
Asia, Europe, North America, and Rest of World (ROW)
Performing market contribution
Asia at 45%
Key consumer countries
US, UK, Germany, Japan, and China
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Companies profiled
Bayer AG, Boehringer Ingelheim International GmbH, Dr. Willmar Schwabe GmbH and Co. KG, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Jazz Pharmaceuticals Plc, Johnson and Johnson Inc., Merck KGaA, Mitsubishi Chemical Corp., Novartis AG, Pierre Fabre SA, Protalix Biotherapeutics Inc., Quintis (Australia) Pty Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Tilray Inc., and Verdure Sciences Inc.
Market Dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period,
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table Of Contents :
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Customer Landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
More news releases in similar topics
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET

source

Add a Comment

Your email address will not be published. Required fields are marked *